Stevioside (SV)
Anti-rotaviral activities of Sophora flavescens extract (SFE) and stevioside (SV) from Stevia rebaudiana Bertoni either singly or in various combinations were examined in vitro and in vivo using a porcine rotavirus G5[P7] strain. Combination of SFE and SV inhibited in vitro virus replication more efficiently than each single treatment. In the piglet model, SV had no effect on rotavirus enteritis, whereas SFE improved but did not completely cure rotaviral enteritis. Interestingly, combination therapy of SFE and SV alleviated diarrhea, and markedly improved small intestinal lesion score and fecal virus shedding. Acute toxicity tests including the piglet lethal dose 50, and body weight, organ weight and pathological changes for the combination therapy did not show any adverse effect on the piglets. These preliminary data suggest that the combination therapy of SV and SFE is a potential curative medication for rotaviral diarrhea in pigs.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Stevioside (SV) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Stevioside (SV) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Stevioside (SV) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Stevioside (SV) CLIA Kit Customized Service Offer
n/a ELISA Kit for Stevioside (SV) ELISA Kit Customized Service Offer